Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$134.41 USD

134.41
417,063

-1.79 (-1.31%)

Updated Apr 30, 2024 04:00 PM ET

After-Market: $134.47 +0.06 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 46% (136 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MASI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Masimo Corporation [MASI]

Reports for Purchase

Showing records 461 - 480 ( 481 total )

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 461

02/14/2011

Company Report

Pages: 5

Q4 RESULTS SHOULD BE INLINE

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 462

02/01/2011

Company Report

Pages: 5

COVIDIEN CHOOSES ROYALTY PAYMENT OVER LITIGATION-RAISING PT -$38 FROM $34

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 463

12/01/2010

Company Report

Pages: 7

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 464

11/03/2010

Company Report

Pages: 6

Beats Q3 Consensus

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 465

10/21/2010

Company Report

Pages: 4

Tangible Evidence of Cost Savings Continues to Accumulate - BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 466

09/08/2010

Company Report

Pages: 4

ANOTHER HOSPITAL SYSTEM WIN SUGGESTS MOMENTUM BUILDING-BUY.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 467

08/26/2010

Daily Note

Pages: 21

THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 75.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 468

08/24/2010

Company Report

Pages: 7

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 469

08/04/2010

Company Report

Pages: 5

BEATS Q2 EXPECTATIONS- BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 470

06/29/2010

Company Report

Pages: 4

FDA APPROVES PRONTO 7 HANDHELD NONINVASIVE HEMOGLOBIN DEVICE - BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 471

06/25/2010

Company Report

Pages: 4

LIMITED MARKET RELEASE OF HANDHELD HEMOGLOBIN MONITOR UDERWAY - BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 472

06/21/2010

Company Report

Pages: 7

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 473

05/13/2010

Company Report

Pages: 5

New Products Should Drive General Floor Monitoring - Buy.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 474

05/05/2010

Company Report

Pages: 6

Q1 EXCEEDS CONSENSUS-MANAGEMENTS MAINTAINS GUIDANCE-BUY.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 475

03/31/2010

Company Report

Pages: 5

POSITIVE CLINICAL DATA CONTINUES TO ACCUMULATE ADDITIONAL DISTRIBUTION ANNOUNCED - BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 476

03/18/2010

Company Report

Pages: 4

POSITIVE MASIMO PATIENT SAFETYNET RESULTS TO BE REPORTED-REITERATE BUY.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 477

03/16/2010

Company Report

Pages: 7

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 478

02/17/2010

Company Report

Pages: 6

Q4 Beats Consensus

Provider: CAPSTONE INVESTMENTS

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 479

02/12/2010

Company Report

Pages: 4

EXPECT COMPANY TO REPORT RESULTS IN LINE WITH CONSENSUS

Provider: CAPSTONE INVESTMENTS

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 480

01/12/2010

Industry Report

Pages: 19

TOP TECHNICAL PICKS AMONG FUNDAMENTAL UNIVERSE.This report contains brief updates on the following: AUTH, COLM, EZCH, IMMR, NTLS, CRUS, MASI, ORA, SURW, ELGX. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: CAPSTONE INVESTMENTS

Analyst: SINE B

Price: 50.00

Research Provided by a Third Party